From April 10–12, 2026, Xihong Biopharma participated in the 23rd MEVOS Congress in Hangzhou, presenting its advanced regenerative injectable portfolio and strengthening global partnerships in OEM manufacturing, private label, and co-registration services
At the exhibition, our core regenerative injectables attracted strong attention from international distributors and brand owners:
PLLA Injectable Filler – collagen stimulation & long-term facial rejuvenation
CaHA Injectable Filler – volume restoration & bio-stimulation
PDRN Skin Booster – skin repair, hydration & regeneration
These products highlight XiHong Biopharma’s expertise in regenerative aesthetics, injectable anti-aging solutions, and advanced skin rejuvenation technologies, supporting partners seeking reliable OEM and ODM injectable suppliers in China.
Built on a strong R&D and GMP manufacturing system, XiHong Biopharma provides end-to-end solutions covering formulation development, private label customization, and regulatory co-registration support for global markets.
Our regenerative platform includes PLLA, CaHA, PCL, PMMA, and PDRN-based injectables, designed for facial anti-aging, skin quality improvement, and body contouring applications.
Next Stop: Istanbul Beauty 2026
📍 Meet us in Istanbul to explore PLLA, CaHA & PDRN OEM injectable opportunities
